Try our Advanced Search for more refined results
May 23, 2014
OTSUKA PHARMACEUTICAL CO., LTD. v. AUROBINDO PHARMA LIMITED et al
Case Number:
1:14-cv-03306
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
May 27, 2014
Otsuka Sues Aurobindo To Halt Generic Abilify
Otsuka Pharmaceutical Co. Ltd. filed suit Friday against Aurobindo Pharma Ltd. and its subsidiaries in New Jersey federal court, alleging Aurobindo's bid to market a generic version of its bipolar disorder, depression and schizophrenia medication Abilify violates its patents.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login